SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Canadian Rocket Red's Picks
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rocket Red who started this subject4/26/2003 12:29:52 PM
From: E. Charters  Read Replies (1) of 19697
 
Rumour on Viragen

"Viragen Inc. [VRA] has begun development of a clinical interferon grade vaccine against Severe Acute Respiratory Syndrome (SARS) using their natural interferon program technology."

hmmmm... don't know quite what to make of that.. sounds like a broker's hype to me..

For one thing coronavirus incubates in the nasal passages, so it has a very poor immune system response. It has many serotypes and many antigen varieties complicating global antibody formation. It is even unresponsive to culture test until at least 10 days after infection. As well as that, it will replicate by RNA transcription and evolves defenses quickly. That is why a vaccine has never been developed against the common cold.

This disease may resond in testing to a technology developed by a Canadian company at Western University whereby silicon chips are linked to biological agents to produce a test matrix device that operates on blood or fluids to provide instant diagnosis for a wide variety of illnesses. The unit cost was supposed to be about 30 dollars, so it not been supported widely. Early diagnosis may be the key to containing the spread. This may not be routinely possible, as the development of detectable live virii or antigens may be dependent on other factors than detection methodology per se.

EC<:-}
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News